The International Society for Cell & Gene Therapy (ISCT) Annual Meeting brings together global leaders in cell and gene therapy to advance clinical translation and commercialisation of CGTs.
Apr 22, 2025

ISCT 2025 Annual Meeting
Date: 7–10 May 2025
Location: Ernest N. Morial Convention Center, New Orleans
The International Society for Cell & Gene Therapy (ISCT) Annual Meeting brings together global leaders in cell and gene therapy to advance clinical translation and commercialisation of CGTs.
Representing eXmoor Pharma at this year’s event will be:
- Angela Osborne, CEO & Founder
- Carol Elvira, Business Development Manager
Ahead of the main conference, Angela Osborne will speak at the ISCT Commercialization Signature Series (CSS) on Tuesday 6 May. This focused, invitation-only forum brings together more than 60 CGT experts, regulatory authorities, and industry leaders to explore how to accelerate patient access by enabling the industrialisation of CGTs. Topics will include PAT, AI-driven analytics, and evolving regulatory expectations.
We’re keen to connect with therapy developers, biotech startups, academic spin-outs and industry partners looking for expert support across process development, GMP manufacturing and CMC strategy. Whether you’re planning for your first clinical trial or scaling up for commercial readiness, we offer integrated consultancy and CDMO services to help accelerate your path to patients.
Attending ISCT 2025?
Connect with Angela or Carol in New Orleans to learn how we support CGT programmes from bench to bedside.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.